Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Stellar Pharmaceuticals Reports the Purchase of Stellar Shares in the Open Market by CEO and CFO
- Stellar Pharmaceuticals Inc., (TSX VENTURE: SLX) (OTCBB: SLXCF) ("Stellar" or the "Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today reported that its CEO, Peter Riehl and CFO, Janice Clarke purchased a total of 20,000 shares of Stellar in the open...
- Research articles 2007-09-25
- Pharma firms property valued. (Management in Brief).(pharmaceutical and health care companies valued correctly, PricewaterhouseCoopers study)(Brief Article)
- Senior executives, consisting mainly of chief financial officers, heads of investor relations, institutional investots and analysts, say most pharmaceuticals and health care companies are valued correctly, notes a Price-waterhouseCoopers study. Alt Senior executives, consisting mainly of chief financial officers, heads of investor relations,...
- Research articles 2002-02-04
- Research and Markets: Wyeth Has planned Four New Launches In 2007 And Secured Entry into the Japanese Rheumatoid Arthritis Market
- DUBLIN, Ireland -- Wyeth is a global leader in pharmaceuticals, consumer healthcare and animal healthcare products. It has three primary businesses: Wyeth Pharmaceuticals Pharmaceuticals, Wyeth Consumer Healthcare Consumer Healthcare and Fort Dodge Animal Health Animal Health.
- Research articles 2006-07-26
- IMS to acquire PharMetrics.(Off the BOARD: Covering the county's public companies)(IMS Health Inc)(Brief Article)
- IMS Health has announced a definitive agreement to acquire PharMetrics Inc., a leading U.S. provider of business intelligence. The combination will provide health-care stakeholders pharmaceutical, medical and hospital insights to better manage the de IMS Health has announced a definitive agreement to acquire PharMetrics Inc.,...
- Research articles 2005-06-13
- Employers, health plans trying various remedies for soaring drug costs.(News)
- Byline: ROBERTO CENICEROS Employers, health plans and pharmaceutical benefit managers are all implementing a variety of measures to help hold down escalating prescription drug expenses. Their efforts-including benefit design changes, co-payment Byline: ROBERTO CENICEROS Employers, health plans...
- Research articles 2003-06-30
- Patent Expiry of Blockbuster Drugs and Push for Lower Healthcare Costs Drive Generic Pharmaceuticals Market
- PALO ALTO, Calif. -- With several major blockbuster drugs reaching patent expiry, the market for generic pharmaceuticals in the United States is booming and is set to witness significant growth over the next few years. Demand for lower healthcare costs and pressure from payers to increase the use of generics...
- Research articles 2007-08-15
- Pharma R&D Spending Expected To Surpass $20 Billion This Year.
- US RESEARCH-BASED pharmaceutical companies are expected to spend $20.6 billion to research and develop new drugs in 1998, a 10.7 percent increase over last year's investment, according to a survey of member companies conducted by the Pharmaceutical R US RESEARCH-BASED pharmaceutical companies are expected to spend...
- Research articles 1998-03-16
- Revision Status of USP Chapter <797> Pharmaceutical Compounding-Sterile Preparations
- The U.S. Pharmacopeia USP 28 is the official source of Chapter <797> Pharmaceutical Compounding-Sterile Preparations. It is currently enforceable by the U.S. Food and Drug Administration FDA. State boards of pharmacy have either adopted The U.S. Pharmacopeia USP 28 is the official source of Chapter <797> Pharmaceutical Compounding-Sterile Preparations. It...
- Research articles 2005-04-01
- Teva to Present at the Morgan Stanley Pharmaceutical CEO's Unplugged Conference and at the 26th Annual JPMorgan Healthcare Conference
- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) will host a live audio webcast at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference in NY and the 26th Annual JPMorgan Healthcare Conference in San-Francisco. Dan Suesskind, Chief Financial Officer and Bill Marth, President & CEO Teva Pharmaceuticals USA will present at Morgan...
- Research articles 2008-01-03
- Sanofi Aventis: because health matters.(Investor fact sheet)(Company Profile)
- The largest pharmaceutical group in Europe and 3rd largest pharmaceutical group in the world The largest pharmaceutical group in Europe and 3rd largest pharmaceutical group in the world
- Research articles 2005-09-01
- Changes in drug regs fuel marketing firm's growth; Pro ED finding success in health care niche.
- Changes in federal regulations of the ultra-competitive pharmaceutical industry have been a boon to Beachwood-based Pro ED Communications. The company, which bills itself as a "health science communications firm," in five years has grown froChanges in federal regulations of the ultra-competitive pharmaceutical industry have been...
- Research articles 1997-02-03
- Good Medicine.(Biotech industry.)
- Byline: Steven Goldberg, Kiplinger Washington Editors Biotech is beginning to realize its potential -- for investors as well as patients. Meanwhile, pharmaceutical companies are continuing to struggle, although they will probably begin to see Byline: Steven Goldberg, Kiplinger...
- Research articles 2005-05-10
- Shomex Expands Its Pharmaceutical & Healthcare Careers Pavilions To St. Louis; Early Bookings By Big Pharma & Healthcare Strong; GlaxoSmithKline, Merck, Sankyo To Exhibit
- ST. LOUIS -- Shomex, a national event producer and the leader in live recruitment solutions, announced today it will be expanding its Pharmaceutical & Healthcare Careers Pavilions to its Diversity Career Fair on March 29, 2005 at the St. Louis Airport Marriott. With the addition of St. Louis, Shomex' Pharmaceutical...
- Research articles 2005-02-16
- Bayer Corp. (Pharma in Brief).(realigned its field sales force)(Brief Article)
- BAYER CORP.'s pharmaceuticals division has realigned its field sales force. Bayer will develop a men's health specialty field force and increase its anti-infective ... BAYER CORP.'s pharmaceuticals division has realigned its field sales force. Bayer will develop a men's health specialty field force...
- Research articles 2002-02-11
- Battle Over Dietary Supplement Heating Up.(Brief Article)
- PHARMACEUTICAL INDUSTRY representatives, dietary supplement manufacturers and public health officials are battling over what vitamin and herbal product makers can claim about health effects. In April 1998, Food and Drug Administration proposed PHARMACEUTICAL INDUSTRY representatives, dietary supplement manufacturers...
- Research articles 1999-08-16
- Othera Pharmaceuticals to Present at SG Cowen's 26th Annual Health Care Conference
- EXTON, Pa. -- Othera Pharmaceuticals, Inc., a specialty pharmaceuticals company focused on treating eye disease, today announced that its Chief Executive Officer David Joseph will be presenting at SG Cowen's 26th Annual Health Care Conference on Tuesday, March 7th, 2006 at 2:30 p.m. ET. The conference is being held at...
- Research articles 2006-02-21
- Bill to bypass pharmaceutical patents in health emergencies is introduced.(in the US House of Representatives)(Brief Article)
- LEGISLATION INTRODUCED in the House of Representatives would make it easier for the federal government to order generic production of patented prescription drugs during health emergencies. The bill sponsored by Rep. Sherrod Brown (D-Ohio) woul LEGISLATION INTRODUCED in the...
- Research articles 2001-11-19
- The US pharmaceutical and related healthcare products company Bristol-Myers Squibb.(completed acquisition of DuPont Pharmaceuticals)
- * The US pharmaceutical and related healthcare products company Bristol-Myers Squibb has confirmed that its $7.8bn acquisition of DuPont ... * The US pharmaceutical and related healthcare products company Bristol-Myers Squibb has confirmed that its $7.8bn acquisition of DuPont Pharmaceuticals Company DuPont Pharma is now...
- Research articles 2001-10-25
- The European distributor, wholesaler and retailer of pharmaceutical and healthcare products, Alliance UniChem plc.(Brief Article)
- * The European distributor, wholesaler and retailer of pharmaceutical and healthcare products, Alliance UniChem plc has announced its figures for the 12 months ended 31 ... * The European distributor, wholesaler and retailer of pharmaceutical and healthcare products, Alliance UniChem plc has announced its figures...
- Research articles 2002-04-10
- Axcan Pharma to Participate in the Gastroenterology Panel at the 2006 RBC Capital Markets Healthcare Conference.
- MONT SAINT-HILAIRE, QUEBEC, Dec 8, 2006 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Wednesday, December 13, 2006, President and Chief Executive Officer, F MONT SAINT-HILAIRE, QUEBEC, Dec 8, 2006 CCNMatthews via COMTEX -- Axcan Pharma Inc....
- Research articles 2006-12-08
- << Previous
- page 1 of 4
- Next >>
Content Types
Refining Tags
- Vertical Industries (28 results)
- Enterprise Software (27 results)
- Software (27 results)
- Healthcare (26 results)
- Benefits (24 results)
- Human Resources (24 results)
- FDA (6 results)
- Pfizer Inc. (6 results)
- Management (5 results)
- Merck & Co. Inc. (5 results)
- Biotechnology (5 results)
- Strategy (5 results)
- sales (5 results)
- Jim Edwards (4 results)
- John Maas (4 results)
- PricewaterhouseCoopers Consulting (4 results)
- Manufacturing (4 results)
- Government (3 results)
- Wyeth (3 results)
- R&D (3 results)
- Bayer AG (3 results)
- Patent (3 results)
- Microsoft Access (3 results)
- Advertisement (3 results)
- Marketing (3 results)
- company (3 results)
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
